Clin2
NCT06964620Possibly a fitRecruiting

Sanggua tablets for early type 2 diabetes or prediabetes

Diabetes Mellitus, Type 2Impaired Glucose Tolerance

Part of Hormones & metabolism clinical trials.

This trial tests whether an herbal medicine called Sanggua tablets can help control blood sugar in people with prediabetes or mild type 2 diabetes who are not yet taking diabetes pills. If you have slightly high blood sugar but don't need medication yet, this study may help you manage it naturally.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
84 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have prediabetes (impaired glucose tolerance) or mild type 2 diabetes that does not require medication.
  • Your most recent HbA1c (a 3-month average blood sugar measure) is between 5.7% and 7.5%.
  • You have not used any diabetes medication (like metformin) in the last 3 months.
  • You do not have serious heart, lung, liver, kidney, or blood diseases, cancer, or poorly controlled high blood pressure.
  • You are not pregnant, planning pregnancy, or breastfeeding, and you are willing to sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02969798Recruiting
Study of prediabetes with abnormal sugars and medicines

This study looks at adults with prediabetes—specifically abnormal fasting and/or 2-hour blood sugar tests—to see whether a treatment helps improve sugar control. You may also be compared with people who have normal blood sugar (the control group).

San Antonio, Texas
NCT06047262Recruiting· Phase 2
Testing dapansutrile for type 2 diabetes and related problems

This trial tests if a drug called dapansutrile can help control blood sugar and reduce inflammation in people with type 2 diabetes. It may also help prevent or manage diabetes-related complications.

Liège
NCT07668388Recruiting· Phase 2
Testing different doses of UBT251 for type 2 diabetes

This trial tests a new medicine, UBT251, to see how well it lowers blood sugar in people with type 2 diabetes. It compares different doses to find the best one for you.

Birmingham, Alabama
NCT06861062Recruiting
Vitamin D and yeast beta-glucan for type 2 diabetes

This trial tests if taking vitamin D3 and yeast beta-glucan supplements can help control blood sugar and lower heart disease risk in people with type 2 diabetes. It may be an option for those who want to see if supplements can improve their diabetes management.

Nanning, Guangxi
NCT07082114Recruiting· Phase 3
Testing a new tablet for type 2 diabetes

This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.

Yueyang, Hunan
NCT07872436Not yet recruiting· Phase 2
VCT220 tablets for type 2 diabetes with poor blood sugar control

This trial tests an oral medication called VCT220, which may help lower blood sugar in adults with type 2 diabetes who aren't well controlled with current treatments. It aims to see if it's safe and effective compared to standard care.

Beijing, Beijing Municipality

Hear when a new Impaired Glucose Tolerance trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.